1. Home
  2. Analysis
  3. Cyclophosphamide
  4. Common-peroneal-nerve-dysfunction

Cyclophosphamide and Common peroneal nerve dysfunction - a phase IV clinical study of FDA data

Summary:

Common peroneal nerve dysfunction is reported as a side effect among people who take Cyclophosphamide (cyclophosphamide), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Prednisolone, and have Non-hodgkin's lymphoma.

The phase IV clinical study analyzes which people have Common peroneal nerve dysfunction when taking Cyclophosphamide. It is created by eHealthMe based on reports of 185,094 people who have side effects when taking Cyclophosphamide from the FDA, and is updated regularly.

What is Cyclophosphamide?

Cyclophosphamide has active ingredients of cyclophosphamide. It is often used in multiple myeloma. eHealthMe is studying from 185,240 Cyclophosphamide users. Check the latest studies of Cyclophosphamide.

What is Common peroneal nerve dysfunction?

Common peroneal nerve dysfunction (dysfunction of nerve controlling movement and sensation to the lower leg, foot and toes) is found to be associated with 651 drugs and 1,130 conditions by eHealthMe. Check the latest studies of Common peroneal nerve dysfunction.

On Aug, 09, 2026

185,094 people reported to have side effects when taking Cyclophosphamide.
Among them, 91 people (0.05%) have Common peroneal nerve dysfunction.

Could Cyclophosphamide cause Common peroneal nerve dysfunction?

Among these 91 people:

How long have people been on Cyclophosphamide when they have Common peroneal nerve dysfunction? *

  • < 1 month: 11.11 %
  • 1 - 6 months: 61.11 %
  • 6 - 12 months: 22.22 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 5.56 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Common peroneal nerve dysfunction when taking Cyclophosphamide? *

  • female: 40.74 %
  • male: 59.26 %

What is the age of people who have Common peroneal nerve dysfunction when taking Cyclophosphamide? *

  • 0-1: 1.43 %
  • 2-9: 2.86 %
  • 10-19: 7.14 %
  • 20-29: 12.86 %
  • 30-39: 11.43 %
  • 40-49: 5.71 %
  • 50-59: 10.0 %
  • 60+: 48.57 %

What are other drugs people take besides Cyclophosphamide? *

  1. Prednisolone: 20 people, 21.98%
  2. Dexamethasone: 14 people, 15.38%
  3. Etoposide: 10 people, 10.99%
  4. Cisplatin: 10 people, 10.99%
  5. Methotrexate: 10 people, 10.99%
  6. Cytarabine: 9 people, 9.89%
  7. Carboplatin: 8 people, 8.79%
  8. Rituxan: 7 people, 7.69%
  9. Ifosfamide: 6 people, 6.59%
  10. Keppra: 6 people, 6.59%

What are other side effects people have besides Common peroneal nerve dysfunction? *

  1. Neuropathy Peripheral (surface nerve damage): 20 people, 21.98%
  2. Weakness: 19 people, 20.88%
  3. Anaemia (lack of blood): 16 people, 17.58%
  4. Thrombocytopenia (decrease of platelets in blood): 15 people, 16.48%
  5. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 15 people, 16.48%
  6. Herpes Zoster: 12 people, 13.19%
  7. Nausea (feeling of having an urge to vomit): 11 people, 12.09%
  8. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 11 people, 12.09%
  9. Gait Disturbance: 10 people, 10.99%
  10. Febrile Neutropenia (fever with reduced white blood cells): 9 people, 9.89%

What are the existing conditions these people have? *

  1. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 14 people, 15.38%
  2. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 7 people, 7.69%
  3. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 6 people, 6.59%
  4. Immunoglobulins Decreased: 6 people, 6.59%
  5. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 5 people, 5.49%
  6. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 4.40%
  7. Drug-Induced Liver Injury (diseases of the liver that are caused by physician-prescribed medications): 3 people, 3.30%
  8. Metastases To Spine (cancer spreads to spine): 2 people, 2.20%
  9. Gait Disturbance: 2 people, 2.20%
  10. Lymphoma (cancer that begins in immune system cells): 2 people, 2.20%

* Approximation only. Some reports may have incomplete information.

Do you take Cyclophosphamide and have Common peroneal nerve dysfunction?

- Check whether Common peroneal nerve dysfunction is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cyclophosphamide:

Common peroneal nerve dysfunction treatments and more:

How severe was Common peroneal nerve dysfunction and when was it recovered:

Expand to all the drugs that have ingredients of cyclophosphamide:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cyclophosphamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Common peroneal nerve dysfunction:

Browse all the conditions that are associated with Common peroneal nerve dysfunction:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on cyclophosphamide (the active ingredients of Cyclophosphamide) and Cyclophosphamide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.